Caracterização bioquímica e efeitos metabólicos do factor de necrose tumoral
Autor(a) principal: | |
---|---|
Data de Publicação: | 1991 |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10451/20156 |
Resumo: | The tumor necrosis factor, preliminary identified because of its antitumor properties, refers to two kinds of similar polypeptides (TNF or cachectin, and TNF-fl or lymphotoxin), which share some biolo gical effects. Both substances, as members of the class of cytokines, play a role as mediators of inflam mation and the celiular immune response. Human cachectin is produced as a prohormone and activated by cleavage of a 76 residue peptide. Mature cachectin (with comprises 157 aminoacid residues) share a 28% aminoacid sequence homology with lymphotoxin. Both cytokines are encoded by different genes of chromosome 6 and may compete for a common receptor. Cachectin is produced by a wide variety of cells (phagocytic and non-phagocytic), mainly by activated macrophages and monocytes. Different inva sive stimuli (mainly lipopolysaccharide, a constituent of the Gram-negative bacteria’s outer wall) acti vate cachectin biosynthesis, which is controlled chiefly at a post-transcriptional levei. The newiy synthetised cachectin remains associated as a transmembrane form, affecting their targets by direct celi-to-cell contact, or is actively secreted in the circuiation to distant sites in the body, where it binds to high affinity cachectin receptor, on a variety of ccli types. Cachectin exerts pleiotropic effects on nor mal, transformed, or tumoral celis. The biological effects mediate by cachectin may be beneficial or deleterious to the body, depending on the quantity produced, duration of ccli exposure and further biochemical mediators in the enviromment of the target edis. Cachexin (frequently associated with severe infection and cancer) seems to be the result of a persistent exposure to raised leveis of cachectin. This cytokine reguiates the activities of different enzymes, thus increasing adipocyte lypolysis and skele tal myocyte glucose catabolism. and increasing hepatocyte gluconeogenesis and acute-phase protein biosynthesis. A very suggestive effect of cachectin is the anti-tumor activity. This cytotoxic-cytolytic effect include hemorrhage and necrosis of some tumor species through mechanisms still open to discus sion. Eventually, two steps may be suggested, one that renders the tumor vessels susceptible to damage with subsequent hemorrhage, the second directly affecting the tumor cells. causing the cdl death. inhibi ting cdl growth, or with no effect. However the therapeutical application of cachectin in cancer is still at preliminary stages and requires further studies that eluciate better the mechanism of action of that cytokinc and eliminate most of its secondary toxicity.. |
id |
RCAP_46a06a8d70a6b1bf77c5134de13ea7f1 |
---|---|
oai_identifier_str |
oai:repositorio.ul.pt:10451/20156 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Caracterização bioquímica e efeitos metabólicos do factor de necrose tumoralBiochemical characterization and metabolic effects of the tumor necrosis factorThe tumor necrosis factor, preliminary identified because of its antitumor properties, refers to two kinds of similar polypeptides (TNF or cachectin, and TNF-fl or lymphotoxin), which share some biolo gical effects. Both substances, as members of the class of cytokines, play a role as mediators of inflam mation and the celiular immune response. Human cachectin is produced as a prohormone and activated by cleavage of a 76 residue peptide. Mature cachectin (with comprises 157 aminoacid residues) share a 28% aminoacid sequence homology with lymphotoxin. Both cytokines are encoded by different genes of chromosome 6 and may compete for a common receptor. Cachectin is produced by a wide variety of cells (phagocytic and non-phagocytic), mainly by activated macrophages and monocytes. Different inva sive stimuli (mainly lipopolysaccharide, a constituent of the Gram-negative bacteria’s outer wall) acti vate cachectin biosynthesis, which is controlled chiefly at a post-transcriptional levei. The newiy synthetised cachectin remains associated as a transmembrane form, affecting their targets by direct celi-to-cell contact, or is actively secreted in the circuiation to distant sites in the body, where it binds to high affinity cachectin receptor, on a variety of ccli types. Cachectin exerts pleiotropic effects on nor mal, transformed, or tumoral celis. The biological effects mediate by cachectin may be beneficial or deleterious to the body, depending on the quantity produced, duration of ccli exposure and further biochemical mediators in the enviromment of the target edis. Cachexin (frequently associated with severe infection and cancer) seems to be the result of a persistent exposure to raised leveis of cachectin. This cytokine reguiates the activities of different enzymes, thus increasing adipocyte lypolysis and skele tal myocyte glucose catabolism. and increasing hepatocyte gluconeogenesis and acute-phase protein biosynthesis. A very suggestive effect of cachectin is the anti-tumor activity. This cytotoxic-cytolytic effect include hemorrhage and necrosis of some tumor species through mechanisms still open to discus sion. Eventually, two steps may be suggested, one that renders the tumor vessels susceptible to damage with subsequent hemorrhage, the second directly affecting the tumor cells. causing the cdl death. inhibi ting cdl growth, or with no effect. However the therapeutical application of cachectin in cancer is still at preliminary stages and requires further studies that eluciate better the mechanism of action of that cytokinc and eliminate most of its secondary toxicity..Inicialmente identificado pela actividade anti-tumoral, o Factor de Necrose Tumoral (TNF, de rumor necrosis factor) engloba, na realidade, dois tipos de polipeptidos (TNFa, ou caquexina, e o TNF J3, ou linfotoxina), com propriedades bioquímicas semelhantes a nível metabólico e imunitário. Estas substancias (reguladoras da inflamacao, da imunidade e defesa a agressão) pertencem a família das citocinas, intervindo como mediadores da intercomunicação celular. A caquexina e produzida como pro-hormona sendo activada por remoção de um péptido de 76 aminoacidos. A molécula activada (com 157 resíduos de aminoácidos) tem cerca de 28% da sua sequencia idêntica a da linfotoxina. Ambas as citocinas sao codificadas por genes diferentes (do cromossoma 6 no homem) e competem para receptores comuns. A caquexina e sintetizada por diversas celulas (fagocitarias e nao-fagocitarias) activadas. sobretudo pelos macrófagos. A biossíntese da caquexina e desencadeada por diversos estímulos (nomeadamente os lipopolissacaridos, das capsulas de bactérias Gram-negativas), apos o que a substancia em circulação interage com os receptores de elevada afinidade presentes nas membranas de tecidos normais, linhagens celulares transformadas ou células tumorais. A consequência da acção do TNFa (protecção ou lesão tecidual) dependem da concentração, duração da acção e presença de outros mediadores no ambiente celular. A caquexia (frequentemente associada a infeccoes graves e doencas tumorais) e atribuível a acção metabólica do TNFa. Esta citocina regula a actividade de diversas enzimas, aumentando o catabolismo lipídico (nas células adiposas) e o catabolismo glicidico (nos miocitos esqueleticos), a par da activação da gliconeogenese e biossíntese das proteínas da fase aguda (pelos hepatocitos). Uma das propriedades mais aliciantes da TNFa advém do seu potencial efeito na regressão tumoral, o que tem sido objecto de pesquisas intensas nos anos mais recentes. A caquexina induz a hemorragia e necrose tumoral por mecanismos ainda pouco esclarecidos. Este efeito poderia ser exercido a dois niveis: através de um intermediário desconhecido que lese as paredes vasculares (originando a hemorragia local), ou por actuação directa nas células tumorais (quer destruindo-as, inibindo-lhes o crescimento ou não tendo qualquer acção). No momento, a utilização terapêutica da TNF na doença tumoral e ainda limitada pelos seus principais efeitos secundáriosOrdem dos MédicosRepositório da Universidade de LisboaMartins e Silva, J.2015-09-29T11:35:25Z19911991-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/20156porActa Médica Portuguesa 1991; 4 Supi. 1 (I):20-271646-0758http://www.actamedicaportuguesa.com/revista/index.php/amp/issue/view/324info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:05:21Zoai:repositorio.ul.pt:10451/20156Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:38:15.798264Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Caracterização bioquímica e efeitos metabólicos do factor de necrose tumoral Biochemical characterization and metabolic effects of the tumor necrosis factor |
title |
Caracterização bioquímica e efeitos metabólicos do factor de necrose tumoral |
spellingShingle |
Caracterização bioquímica e efeitos metabólicos do factor de necrose tumoral Martins e Silva, J. |
title_short |
Caracterização bioquímica e efeitos metabólicos do factor de necrose tumoral |
title_full |
Caracterização bioquímica e efeitos metabólicos do factor de necrose tumoral |
title_fullStr |
Caracterização bioquímica e efeitos metabólicos do factor de necrose tumoral |
title_full_unstemmed |
Caracterização bioquímica e efeitos metabólicos do factor de necrose tumoral |
title_sort |
Caracterização bioquímica e efeitos metabólicos do factor de necrose tumoral |
author |
Martins e Silva, J. |
author_facet |
Martins e Silva, J. |
author_role |
author |
dc.contributor.none.fl_str_mv |
Repositório da Universidade de Lisboa |
dc.contributor.author.fl_str_mv |
Martins e Silva, J. |
description |
The tumor necrosis factor, preliminary identified because of its antitumor properties, refers to two kinds of similar polypeptides (TNF or cachectin, and TNF-fl or lymphotoxin), which share some biolo gical effects. Both substances, as members of the class of cytokines, play a role as mediators of inflam mation and the celiular immune response. Human cachectin is produced as a prohormone and activated by cleavage of a 76 residue peptide. Mature cachectin (with comprises 157 aminoacid residues) share a 28% aminoacid sequence homology with lymphotoxin. Both cytokines are encoded by different genes of chromosome 6 and may compete for a common receptor. Cachectin is produced by a wide variety of cells (phagocytic and non-phagocytic), mainly by activated macrophages and monocytes. Different inva sive stimuli (mainly lipopolysaccharide, a constituent of the Gram-negative bacteria’s outer wall) acti vate cachectin biosynthesis, which is controlled chiefly at a post-transcriptional levei. The newiy synthetised cachectin remains associated as a transmembrane form, affecting their targets by direct celi-to-cell contact, or is actively secreted in the circuiation to distant sites in the body, where it binds to high affinity cachectin receptor, on a variety of ccli types. Cachectin exerts pleiotropic effects on nor mal, transformed, or tumoral celis. The biological effects mediate by cachectin may be beneficial or deleterious to the body, depending on the quantity produced, duration of ccli exposure and further biochemical mediators in the enviromment of the target edis. Cachexin (frequently associated with severe infection and cancer) seems to be the result of a persistent exposure to raised leveis of cachectin. This cytokine reguiates the activities of different enzymes, thus increasing adipocyte lypolysis and skele tal myocyte glucose catabolism. and increasing hepatocyte gluconeogenesis and acute-phase protein biosynthesis. A very suggestive effect of cachectin is the anti-tumor activity. This cytotoxic-cytolytic effect include hemorrhage and necrosis of some tumor species through mechanisms still open to discus sion. Eventually, two steps may be suggested, one that renders the tumor vessels susceptible to damage with subsequent hemorrhage, the second directly affecting the tumor cells. causing the cdl death. inhibi ting cdl growth, or with no effect. However the therapeutical application of cachectin in cancer is still at preliminary stages and requires further studies that eluciate better the mechanism of action of that cytokinc and eliminate most of its secondary toxicity.. |
publishDate |
1991 |
dc.date.none.fl_str_mv |
1991 1991-01-01T00:00:00Z 2015-09-29T11:35:25Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10451/20156 |
url |
http://hdl.handle.net/10451/20156 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
Acta Médica Portuguesa 1991; 4 Supi. 1 (I):20-27 1646-0758 http://www.actamedicaportuguesa.com/revista/index.php/amp/issue/view/324 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134282111778816 |